- Total Voting Rights
- Participation in Upcoming Investor Conference
- MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
- Signing of Strategic Platform License
- MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
- Holding(s) in Company
- Filing of Form 10-Q
- First Quarter Results
- MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
- Notice of AGM
More ▼
Key statistics
On Friday, MaxCyte Inc (MXCT:NSQ) closed at 4.86, -12.35% below its 52-week high of 5.55, set on Jan 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.79 |
---|---|
High | 4.95 |
Low | 4.67 |
Bid | 4.12 |
Offer | 5.01 |
Previous close | 4.83 |
Average volume | 322.11k |
---|---|
Shares outstanding | 104.54m |
Free float | 98.13m |
P/E (TTM) | -- |
Market cap | 466.27m USD |
EPS (TTM) | -0.3532 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.
More ▼